MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$185,011K
(-14.40%↓ Y/Y)
Trade receivables
$106,818K
(35.09%↑ Y/Y)
Cash and cash
equivalents
$89,736K
(-14.30%↓ Y/Y)
Prepaid expenses and
other current assets
$17,182K
(24.94%↑ Y/Y)
Inventory, net
$5,398K
(-33.25%↓ Y/Y)
Restricted cash
$201K
(-4.29%↓ Y/Y)
Total current assets
$404,346K
(-4.18%↓ Y/Y)
Long-term investments
$61,164K
(200.96%↑ Y/Y)
Long-term inventory, net
$23,990K
(3.46%↑ Y/Y)
Right of use assets
$10,203K
(-15.03%↓ Y/Y)
Property and equipment,
net
$8,783K
(12.94%↑ Y/Y)
Other assets
$5,672K
(9.99%↑ Y/Y)
Total assets
$514,158K
(4.84%↑ Y/Y)
Accumulated deficit
-$1,506,179K
(14.91%↑ Y/Y)
Total liabilities and
stockholders deficit
$514,158K
(4.84%↑ Y/Y)
Total stockholders
deficit
-$119,153K
(74.96%↑ Y/Y)
Additional paid-in capital
$1,384,857K
(7.26%↑ Y/Y)
Common stock, 0.01 par
value shares...
$2,131K
(2.21%↑ Y/Y)
Accumulated other
comprehensive income
$38K
(-95.87%↓ Y/Y)
Total liabilities
$633,311K
(-34.46%↓ Y/Y)
Royalty financing
obligations
$427,233K
(-11.19%↓ Y/Y)
Total current
liabilities
$196,066K
(22.25%↑ Y/Y)
Operating lease
liabilities
$8,571K
(8.17%↑ Y/Y)
Finance lease
liabilities
$1,441K
(-32.16%↓ Y/Y)
Accrued expenses
$126,413K
(11.58%↑ Y/Y)
Royalty financing
obligations
$38,455K
(17.69%↑ Y/Y)
Accounts payable
$15,826K
(35.92%↑ Y/Y)
Share-based liability
$13,743K
Finance lease
liabilities
$1,312K
(-28.50%↓ Y/Y)
Operating lease
liabilities
$317K
(-66.17%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)